Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Post-Stroke Epilepsy with Levetiracetam or Perampanel
NCT04858841Unknown
- Sponsor
- National Cheng Kung University
- Start
- Aug 2020
- Primary completion
- Jul 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised trial in epilepsy comparing Levetiracetam, Perampanel and Placebo (3 arms). Primary endpoint: Post-stroke epileptic seizure at 14 days. Status: unknown.
02
Drugs
levetiracetamperampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04858841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858841.